• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞/β(+)地中海贫血成年患者慢性肝内胆汁淤积症的成功治疗结果

Successful Outcome of Chronic Intrahepatic Cholestasis in an Adult Patient with Sickle Cell/ β (+) Thalassemia.

作者信息

Vlachaki Efthymia, Andreadis Panagiotis, Neokleous Nikolaos, Agapidou Aleka, Vetsiou Evaggelia, Katsinelos Panagiotis, Boura Panagiota

机构信息

Adults Thalassemia Unit, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.

Department of Gastroenterology, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.

出版信息

Case Rep Hematol. 2014;2014:213631. doi: 10.1155/2014/213631. Epub 2014 Feb 9.

DOI:10.1155/2014/213631
PMID:24660076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3934305/
Abstract

Sickle cell/β (+) thalassemia (Hb S/β (+)thal) is considered as a variant form of sickle cell disease. Acute episodes of vasoocclusive pain crisis are characteristic for sickle cell disorders and may be complicated by an acute or chronic life-threatening organ dysfunction. Chronic intrahepatic cholestasis is a rare and severe complication in sickle cell disease, characterized by marked hyperbilirubinemia and acute hepatic failure with an often fatal course. Despite the fact that patients with Hb S/β (+)thal usually have a mild type of disease, herein we describe an interesting case of chronic intrahepatic cholestasis with successful outcome in an adult patient with Hb S/β (+)thal.

摘要

镰状细胞/β(+)地中海贫血(Hb S/β(+)thal)被认为是镰状细胞病的一种变异形式。血管闭塞性疼痛危象的急性发作是镰状细胞疾病的特征,可能并发急性或慢性危及生命的器官功能障碍。慢性肝内胆汁淤积是镰状细胞病中一种罕见且严重的并发症,其特征为显著的高胆红素血症和急性肝衰竭,通常病程致命。尽管Hb S/β(+)thal患者通常病情较轻,但在此我们描述了一例成年Hb S/β(+)thal患者发生慢性肝内胆汁淤积且预后良好的有趣病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b9/3934305/040e1996f332/CRIM.HEMATOLOGY2014-213631.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b9/3934305/040e1996f332/CRIM.HEMATOLOGY2014-213631.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b9/3934305/040e1996f332/CRIM.HEMATOLOGY2014-213631.001.jpg

相似文献

1
Successful Outcome of Chronic Intrahepatic Cholestasis in an Adult Patient with Sickle Cell/ β (+) Thalassemia.镰状细胞/β(+)地中海贫血成年患者慢性肝内胆汁淤积症的成功治疗结果
Case Rep Hematol. 2014;2014:213631. doi: 10.1155/2014/213631. Epub 2014 Feb 9.
2
Sickle Cell Intrahepatic Cholestasis: Extremely Rare but Fatal Complication of Sickle Cell Disease.镰状细胞性肝内胆汁淤积症:镰状细胞病极其罕见但致命的并发症。
Cureus. 2022 Feb 9;14(2):e22050. doi: 10.7759/cureus.22050. eCollection 2022 Feb.
3
Hb S (: c.20A>T) and α- and β-Thalassemia Coinheritance in Iranian Patients.伊朗患者中 Hb S(: c.20A>T)与α-和β-地贫的共遗传。
Hemoglobin. 2020 Mar;44(2):109-112. doi: 10.1080/03630269.2020.1757462. Epub 2020 May 6.
4
Hb S/-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.REDS-III 巴西镰状细胞病队列中的 Hb S/-地中海贫血:临床、实验室和分子特征。
Hemoglobin. 2020 Jan;44(1):1-9. doi: 10.1080/03630269.2020.1731530. Epub 2020 Mar 16.
5
Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.印度恰蒂斯加尔邦不同人群中β地中海贫血与镰状细胞血红蛋白的复合杂合性
Hemoglobin. 2018 Mar;42(2):84-90. doi: 10.1080/03630269.2018.1483946.
6
Orthotropic Liver Transplantation for Acute Intrahepatic Cholestasis in Sickle Cell Disease: Clinical and Histopathologic Features of a Rare Case.镰状细胞病急性肝内胆汁淤积的原位肝移植:1例罕见病例的临床和组织病理学特征
Int J Surg Pathol. 2019 Jun;27(4):411-417. doi: 10.1177/1066896918798467. Epub 2018 Sep 10.
7
Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient.一名非裔美国患者尽管接受了换血治疗,但仍发生致命性镰状细胞性肝内胆汁淤积的病例。
J Natl Med Assoc. 2006 Jul;98(7):1183-7.
8
Intrahepatic Cholestasis in a Pregnant Patient With Sickle Cell Disease: A Case Report.镰状细胞病孕妇的肝内胆汁淤积症:一例报告
Cureus. 2024 May 19;16(5):e60611. doi: 10.7759/cureus.60611. eCollection 2024 May.
9
Receptor Activator of Nuclear Factor κ-Β Ligand/Osteoprotegerin Axis in Adults with Hb S/β-Thalassemia and β-Thalassemia Trait.成人血红蛋白 S/β-地中海贫血和β-地中海贫血特征者核因子 κB 受体激活剂配体/骨保护素轴。
Hemoglobin. 2020 Sep;44(5):334-337. doi: 10.1080/03630269.2020.1811116. Epub 2020 Sep 2.
10
Successful liver transplantation for acute sickle cell intrahepatic cholestasis: A case report and review of the literature.急性镰状细胞性肝内胆汁淤积症的成功肝移植:一例报告及文献综述
World J Hepatol. 2020 Mar 27;12(3):108-115. doi: 10.4254/wjh.v12.i3.108.

引用本文的文献

1
Sickle Cell Disease: Current Understanding and Future Options.镰状细胞病:当前认识与未来选择
J Clin Med. 2023 Sep 13;12(18):5943. doi: 10.3390/jcm12185943.
2
Management of Sickle Cell Intrahepatic Cholestasis: An Argument in Favor of Automated Exchange Transfusion.镰状细胞性肝内胆汁淤积症的管理:支持自动换血疗法的观点
Clin Hematol Int. 2019 Sep 1;1(3):127-133. doi: 10.2991/chi.d.190630.001. eCollection 2019 Sep.
3
Sickle Hepatopathy.镰状细胞性肝病

本文引用的文献

1
Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacy.MAP3K5 基因的基因组变异与 β-地中海贫血疾病严重程度和羟基脲治疗效果相关。
Pharmacogenomics. 2013 Apr;14(5):469-83. doi: 10.2217/pgs.13.31.
2
Safety and efficacy of 4 years of deferasirox treatment for sickle cell disease patients.去铁胺对镰状细胞病患者进行4年治疗的安全性和有效性
Hemoglobin. 2013;37(1):94-100. doi: 10.3109/03630269.2012.746696. Epub 2012 Dec 7.
3
How I use hydroxyurea to treat young patients with sickle cell anemia.
J Clin Exp Hepatol. 2021 Jan-Feb;11(1):82-96. doi: 10.1016/j.jceh.2020.08.003. Epub 2020 Aug 9.
4
Reversal of liver function without exchange transfusion in sickle cell intrahepatic cholestasis.镰状细胞性肝内胆汁淤积症无需换血即可逆转肝功能
Proc (Bayl Univ Med Cent). 2014 Oct;27(4):361-3. doi: 10.1080/08998280.2014.11929160.
我如何使用羟基脲治疗年轻的镰状细胞贫血患者。
Blood. 2010 Jul 1;115(26):5300-11. doi: 10.1182/blood-2009-04-146852. Epub 2010 Mar 11.
4
Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment.镰状细胞病中的肝功能障碍:基于整体评估的新分类系统
Clin Gastroenterol Hepatol. 2007 Dec;5(12):1469-76; quiz 1369. doi: 10.1016/j.cgh.2007.08.009. Epub 2007 Sep 27.
5
Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient.一名非裔美国患者尽管接受了换血治疗,但仍发生致命性镰状细胞性肝内胆汁淤积的病例。
J Natl Med Assoc. 2006 Jul;98(7):1183-7.
6
Acute hepatic sequestration in sickle cell disease.镰状细胞病中的急性肝内血液淤滞
J Natl Med Assoc. 2004 Sep;96(9):1235-9.
7
Resolution of chronic hepatic sequestration in a patient with homozygous sickle cell disease receiving hydroxyurea.接受羟基脲治疗的纯合子镰状细胞病患者慢性肝内瘀血的消退
J Pediatr Hematol Oncol. 2003 Mar;25(3):257-60. doi: 10.1097/00043426-200303000-00015.
8
Sicklemia with multi-organ failure syndrome and thrombotic thrombocytopenic purpura.镰状细胞血症伴多器官功能衰竭综合征和血栓性血小板减少性紫癜。
Hemoglobin. 2002 Nov;26(4):345-51. doi: 10.1081/hem-120016371.
9
Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy.急性镰状细胞性肝病是经皮肝穿刺活检的潜在禁忌证。
Blood. 2003 Jan 1;101(1):101-3. doi: 10.1182/blood-2002-06-1823. Epub 2002 Aug 15.
10
Chronic intrahepatic cholestasis in sickle cell disease requiring exchange transfusion.镰状细胞病中需要换血治疗的慢性肝内胆汁淤积
Gut. 1995 Jul;37(1):144-7. doi: 10.1136/gut.37.1.144.